Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance

Infection and Immunity

Volumn 69, Issue 8, 2001, Pages 5010-5015

  Bakke, H ^a   Lie, K ^a   Haugen, I L ^a   Korsvold, G E ^a   Hooiby E A ^a   Naess L M ^a   Holst, J ^a   Aaberge, I S ^a   Oftung, F ^a   Haneberg, B ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MENINGOCOCCUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERICIDAL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; MEMBRANE VESICLE; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SALIVA ANALYSIS; SPLEEN CELL; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CELL DIVISION; FEMALE; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; INJECTIONS, SUBCUTANEOUS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS; SPLEEN;

EID: 0034912423     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.8.5010-5015.2001     Document Type: Article

References (27)

1. SCID-Hu mice immunized with a pneumococcal vaccine produce specific human antibodies and show increased resistance to infection
2. A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin
3. Nature and properties of the human gastrointestinal immune system
4. The B-cell system of human mucosae and exocrine glands
5. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines
6. Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice
7. Production, characterization and control of MenB-vaccine "Folkehelsa": An outer membrane vesicle vaccine against group B meningococcal disease
8. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina, measured by a new method for collection of secretions from local mucosal surfaces
9. Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans
10. Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: A brief survey
11. Nasal immunization with group B streptococci can induce high levels of specific IgA antibodies in cervicovaginal secretions of mice
12. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding
13. Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects against systemic pneumococcal infection
14. The immunological consequences of feeding cholera toxin. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity
15. Consideration of mucosally induced tolerance in vaccine development
16. Induction of tolerance via the respiratory mucosa
17. Long-term cholera antitoxin memory in the gut can be triggered to antibody formation associated with protection within hours of an oral challenge immunization
18. The mucosal immune system: From fundamental concepts to vaccine development
19. The common mucosal immune system and current strategies for induction of immune responses in external secretions
20. Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine
21. Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine
22. Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
23. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine
24. Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit
25. Natural history of pertussis antibody in the infant and effect on vaccine response
26. New strategies for using mucosal vaccination to achieve more effective immunization
27. Polioviruses and mucosal vaccines